News
VFMCRP and Cara Therapeutics announce European Medicines Agency has accepted to review the Marketing Authorization Application for difelikefalin
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210329005652/en/
Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
Vifor Pharma to propose Åsa Riisberg for appointment to Board of Directors
Regulatory News:
Vifor Pharma is pleased to announce that the Board of Directors will propose Åsa Riisberg for election to the Board at the Annual General Meeting on 6 May 2021.
Åsa Riisberg, a
Vifor Pharma and Cara Therapeutics announce U.S. FDA acceptance and Priority Review of NDA for KORSUVA™* injection in hemodialysis patients with moderate-to-severe pruritus
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210307005039/en/
Vifor Pharma and Cara Therapeutics, Inc. (Nasdaq
Vifor Pharma delivers strong full year results 2020 with an EBITDA of 576 million Swiss Francs representing over 29% growth1
Regulatory News:
Vifor Pharma Group reported stable net sales and a continued strong increase in profitability in 2020, despite challenges to patient access from COVID-19 and the impact of a much
Vifor Pharma schliesst 2020 mit starkem Geschäftsergebnis und EBITDA-Anstieg um über 29% auf 576 Millionen Schweizer Franken ab1
Regulatory News:
Die Vifor Pharma Gruppe weist auch für 2020 trotz des durch COVID-19 erschwerten Patientenzugangs und den Folgen des gegenüber dem US-Dollar deutlich stärkeren Schweizer Franken
Vifor Pharma to propose Dr Alexandre LeBeaut as Board member
Regulatory News:
Vifor Pharma today announced that the Board of Directors will propose Dr Alexandre LeBeaut for election to the Board at the next Annual General Meeting on 6 May 2021.
Jacques
VFMCRP and ChemoCentryx Provide Topline Results From ACCOLADE Trial of Avacopan in C3 Glomerulopathy Including Improved Estimated Glomerular Filtration Rate (eGFR)
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201221005694/en/
Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
Vifor Pharma supports Iron Deficiency Day 2020 to highlight global impact on health and gender inequality
Regulatory News:
Vifor Pharma is marking the sixth anniversary of Iron Deficiency Day, focused on raising international awareness of the serious health impact of iron deficiency and iron
VFMCRP and Fresenius Kabi expand collaboration in nephrology in China with Veltassa® agreement
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201118005914/en/
Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
Full Results From AFFIRM-AHF Study Show Ferinject® Significantly Reduces Hospitalizations After Acute Heart Failure in Patients With Iron Deficiency
Regulatory News:
Vifor Pharma today presented the full results from the AFFIRM-AHF study at the 2020 American Heart Association (AHA) Scientific Sessions virtual congress. Simultaneously, results
Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201108005065/en/
Vifor Pharma and Angion Biomedica Corp. (Angion)
VFMCRP and ChemoCentryx announce European Medicines Agency has accepted to review the Marketing Authorization Application for avacopan
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201102005955/en/
Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
BB Biotech: Ein drittes Quartal zum Abhaken
BB Biotech (WKN: A0NFN3) legte heute seinen Quartalsbericht vor und informierte zugleich über „erhöhte Übernahmeaktivitäten“ im Pharmasektor, aus denen die Investmentgesellschaft selbst Kapital
Vifor Pharma and Cara Therapeutics sign US license agreement for i.v. Korsuva™* to treat dialysis patients with pruritus
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201019005725/en/
Vifor Pharma and Cara Therapeutics, Inc
Santhera: Endgültiger Studienstopp von DMD-Medikament
Dämpfer für Santhera Pharmaceuticals (WKN: A0LCUK): Die Schweizer Biotechschmiede stellt die zulassungsrelevante Phase-3-Studie mit Puldysa bei Patienten mit Duchenne-Muskeldystrophie (DMD) ein. Die
Vifor Pharma announces outcome of AFFIRM-AHF topline data
Regulatory News:
Vifor Pharma today announced topline data from its AFFIRM-AHF study evaluating the effect of Ferinject® (intravenous ferric carboxymaltose) on heart failure hospitalizations and
Vifor Pharma Group Announces Successful Sale of OM Pharma
Regulatory News:
Vifor Pharma has today announced the successful sale of 100% of the share capital of OM Pharma, a Vifor Pharma Group company to Optimus Holding Ltd. The terms of the deal
Vifor Pharma Appoints Gregory Oakes as President North America and Member of the Executive Committee
Regulatory News:
Vifor Pharma today announced the appointment of Gregory Oakes as EVP, President North America and member of the Vifor Pharma Executive Committee as of September 1, 2020.
Vifor Pharma Group Reports Continued Growth in H1 2020
Regulatory News:
Vifor Pharma Group reported growth in H1 2020, despite challenges to patient access conditions caused by the COVID-19 pandemic. The financial guidance has been updated to reflect
Vifor Pharma Gruppe wächst auch im 1. Halbjahr 2020 weiter
Regulatory News:
Die Vifor Pharma Gruppe ist trotz der Herausforderungen, die Patienten auch während der COVID-19-Pandemie zu erreichen, im 1. Halbjahr 2020 weiter gewachsen. Die Finanzprognose
VFMCRP and ChemoCentryx announce topline data from phase-II LUMINA-1 trial of CCX140 in Focal Segmental Glomerulosclerosis (FSGS)
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200517005052/en/
Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
92. Generalversammlung der Vifor Pharma Gruppe
Regulatory News:
An der 92. ordentlichen Generalversammlung der Vifor Pharma AG haben die Aktionäre alle Beschlussanträge des Verwaltungsrats genehmigt.
Aufgrund der aktuellen Situation und im
92nd Vifor Pharma Group Annual General Meeting
Regulatory News:
At the 92nd Annual General Meeting of Vifor Pharma Ltd., shareholders approved all proposed resolutions put forward by the Board of Directors.
In view of the current situation
Vifor Pharma Announces Akebia’s Positive Top-Line Results From Global Phase-III Program of vadadustat for Treatment of Anaemia Due to Chronic Kidney Disease in Adult Dialysis-Dependent Patients
Regulatory News:
Vifor Pharma announced that its partner, Akebia Therapeutics, Inc., today reported positive top-line results from INNO2VATE, Akebia’s global phase-III cardiovascular outcomes
BB Biotech: So geht Rendite mit COVID-19-Aktien!
Interessante Einblicke in den Geschäftsverlauf im Auftaktquartal liefert heute BB Biotech (WKN: A0NFN3). Die mussten zwar Rückschläge einstecken, glänzten aber auch durch Überraschungen – die mit